1. From Janssen Research & Development, Raritan, New Jersey; Sideview, Princes Risborough, United Kingdom; Novo Nordisk, Bagsværd, Denmark; Nucleus Global, London, United Kingdom; Ashfield Healthcare Communications, Macclesfield, United Kingdom; PharmacoEconomics, Springer International Publishing, Cham, Switzerland; New York Medical College, Valhalla, New York; MedImmune, Gaithersburg, Maryland; Pfizer, New York, New York; Medtronic, Mounds View, Minnesota;
2. Bristol-Myers Squibb, Philadelphia, Pennsylvania; Baxalta, Deerfield, Illinois; Keithveitch Communications, Amsterdam, The Netherlands; ProScribe (Envision Pharma Group), Sydney, Australia; and Medicite, Yardley, Pennsylvania.